Joel Greenblatt Novavax Inc Transaction History

Gotham Asset Management, LLC

  • $9.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$112.98 - $319.93 $9.78 Million - $27.7 Million
-86,608 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$78.74 - $139.5 $4,094 - $7,254
-52 Reduced 0.06%
86,608 $9.66 Million
Q3 2020

Nov 16, 2020
SELL
$79.44 - $178.51 $2.54 Million - $5.71 Million
-31,981 Reduced 26.96%
86,660 $9.39 Million
Q2 2020

Aug 13, 2020
BUY
$13.86 - $83.61 $1.64 Million - $9.92 Million
118,641 New
118,641 $9.89 Million

Others Institutions Holding NVAX

# of Institutions
292
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email